General introduction 27 1 REFERENCES: 1. Piret J, Boivin G. Pandemics Throughout History. Frontiers in Microbiology 2021; 11. 2. WHO. WORKSHOP ON PRIORITIZATION OF PATHOGENS. World Health Organization (WHO) 2015; Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens. 3. WHO. WHO Coronavirus (COVID-19) Dashboard. 2022; World Health Organization. 4. Pro-MED. Undiagnosed pneumonia - China (HU): Request For Information, 2019 30 Dec 2019. 5. Tan W, Zhao X, Ma X, et al. A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases - Wuhan, China 2019-2020. China CDC Wkly 2020; 2(4): 61-2. 6. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. (1474-547X (Electronic)). 7. WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available at: https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-theinternational-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-ofnovel-coronavirus-(2019-ncov). Accessed 6 June. 8. WHO. Novel Coronavirus(2019-nCoV) Situation Report - 10. Geneva, Switzerland, 2020. 9. WHO. Coronavirus disease 2019 (COVID-19) Situation Report – 101. Geneva, Switzerland, 2020 30 April 2020. 10. Gandhi M, Yokoe DS, Havlir DV. Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19. New England Journal of Medicine 2020; 382(22): 2158-60. 11. Cheng PK, Wong Da Fau - Tong LKL, Tong Lk Fau - Ip S-M, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. (1474-547X (Electronic)). 12. Peiris JS, Chu Cm Fau - Cheng VCC, Cheng Vc Fau - Chan KS, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. (0140-6736 (Print)). 13. Boyton RJ, Altmann DM. The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions? Nature Reviews Immunology 2021; 21(12): 762-8. 14. Mugglestone MA, Ratnaraja NV, Bak A, et al. Presymptomatic, asymptomatic and postsymptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance. BMC Infectious Diseases 2022; 22(1): 453. 15. WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. In: (WHO) WHO. Geneva, Switzerland, 2020. 16. Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology 2019; 17(3): 181-92. 17. Tao Y, Shi M, Chommanard C, et al. Surveillance of Bat Coronaviruses in Kenya Identifies Relatives of Human Coronaviruses NL63 and 229E and Their Recombination History. LID - 10.1128/JVI.01953-16 [doi] LID - e01953-16. (1098-5514 (Electronic)). 18. Hu B, Ge X, Wang L-F, Shi Z. Bat origin of human coronaviruses. Virology Journal 2015; 12(1): 221.
RkJQdWJsaXNoZXIy MTk4NDMw